F&FFinancial Insights

Financial Metrics

SHC Sotera Health Co
Range: 2016-01-01 to 2026-04-29
Chart Range:
% Change:

Financial Statements

Grouped by statement

Income Statement

Metrics: 6

Revenue

Q: 18 | A: 7

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2020-03-31 188200000.0 USD 10-Q 2021-05-13
Quarterly 2020-06-30 213085000.0 +13.2% USD 10-Q 2021-08-12
Quarterly 2020-09-30 200028000.0 -6.1% USD 10-Q 2021-11-10
Quarterly 2021-03-31 212148000.0 +6.1% USD 10-Q 2022-05-05
Quarterly 2021-06-30 251917000.0 +18.7% USD 10-Q 2022-08-04
Quarterly 2021-09-30 226164000.0 -10.2% USD 10-Q 2022-11-02
Quarterly 2022-03-31 236754000.0 +4.7% USD 10-Q 2023-05-03
Quarterly 2022-06-30 266639000.0 +12.6% USD 10-Q 2023-08-03
Quarterly 2022-09-30 248704000.0 -6.7% USD 10-Q 2023-11-01
Quarterly 2023-03-31 220590000.0 -11.3% USD 10-Q 2024-05-02
Quarterly 2023-06-30 255282000.0 +15.7% USD 10-Q 2024-08-05
Quarterly 2023-09-30 263177000.0 +3.1% USD 10-Q 2024-11-05
Quarterly 2024-03-31 248176000.0 -5.7% USD 10-Q 2025-05-01
Quarterly 2024-06-30 276594000.0 +11.5% USD 10-Q 2025-08-08
Quarterly 2024-09-30 285468000.0 +3.2% USD 10-Q 2025-11-04
Quarterly 2025-03-31 254523000.0 -10.8% USD 10-Q 2025-05-01
Quarterly 2025-06-30 294341000.0 +15.6% USD 10-Q 2025-08-08
Quarterly 2025-09-30 311312000.0 +5.8% USD 10-Q 2025-11-04
Annual 2019-12-31 778327000.0 USD 10-K 2022-03-01
Annual 2020-12-31 818158000.0 +5.1% USD 10-K 2023-02-28
Annual 2021-12-31 931478000.0 +13.9% USD 10-K 2024-02-27
Annual 2022-12-31 1003687000.0 +7.8% USD 10-K 2025-02-27
Annual 2023-12-31 1049288000.0 +4.5% USD 10-K 2026-02-24
Annual 2024-12-31 1100441000.0 +4.9% USD 10-K 2026-02-24
Annual 2025-12-31 1163617000.0 +5.7% USD 10-K 2026-02-24

Gross Profit

Q: 18 | A: 7

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2020-03-31 96517000.0 USD 10-Q 2021-05-13
Quarterly 2020-06-30 118967000.0 +23.3% USD 10-Q 2021-08-12
Quarterly 2020-09-30 107511000.0 -9.6% USD 10-Q 2021-11-10
Quarterly 2021-03-31 115372000.0 +7.3% USD 10-Q 2022-05-05
Quarterly 2021-06-30 143761000.0 +24.6% USD 10-Q 2022-08-04
Quarterly 2021-09-30 125586000.0 -12.6% USD 10-Q 2022-11-02
Quarterly 2022-03-31 128875000.0 +2.6% USD 10-Q 2023-05-03
Quarterly 2022-06-30 150396000.0 +16.7% USD 10-Q 2023-08-03
Quarterly 2022-09-30 136013000.0 -9.6% USD 10-Q 2023-11-01
Quarterly 2023-03-31 111503000.0 -18.0% USD 10-Q 2024-05-02
Quarterly 2023-06-30 139588000.0 +25.2% USD 10-Q 2024-08-05
Quarterly 2023-09-30 145984000.0 +4.6% USD 10-Q 2024-11-05
Quarterly 2024-03-31 127115000.0 -12.9% USD 10-Q 2025-05-01
Quarterly 2024-06-30 152791000.0 +20.2% USD 10-Q 2025-08-08
Quarterly 2024-09-30 158024000.0 +3.4% USD 10-Q 2025-11-04
Quarterly 2025-03-31 135432000.0 -14.3% USD 10-Q 2025-05-01
Quarterly 2025-06-30 166621000.0 +23.0% USD 10-Q 2025-08-08
Quarterly 2025-09-30 177561000.0 +6.6% USD 10-Q 2025-11-04
Annual 2019-12-31 395431000.0 USD 10-K 2022-03-01
Annual 2020-12-31 443572000.0 +12.2% USD 10-K 2023-02-28
Annual 2021-12-31 518672000.0 +16.9% USD 10-K 2024-02-27
Annual 2022-12-31 557004000.0 +7.4% USD 10-K 2025-02-27
Annual 2023-12-31 577158000.0 +3.6% USD 10-K 2026-02-24
Annual 2024-12-31 602295000.0 +4.4% USD 10-K 2026-02-24
Annual 2025-12-31 645534000.0 +7.2% USD 10-K 2026-02-24

Operating Income

Q: 15 | A: 6

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2020-03-31 44865000.0 USD 10-Q 2021-05-13
Quarterly 2020-06-30 61742000.0 +37.6% USD 10-Q 2021-08-12
Quarterly 2020-09-30 47030000.0 -23.8% USD 10-Q 2021-11-10
Quarterly 2021-03-31 46364000.0 -1.4% USD 10-Q 2022-05-05
Quarterly 2021-06-30 78272000.0 +68.8% USD 10-Q 2022-08-04
Quarterly 2021-09-30 65671000.0 -16.1% USD 10-Q 2022-11-02
Quarterly 2022-03-31 53492000.0 -18.5% USD 10-Q 2023-05-03
Quarterly 2022-06-30 71495000.0 +33.7% USD 10-Q 2023-08-03
Quarterly 2022-09-30 63195000.0 -11.6% USD 10-Q 2023-11-01
Quarterly 2023-03-31 33366000.0 -47.2% USD 10-Q 2024-05-02
Quarterly 2023-06-30 63204000.0 +89.4% USD 10-Q 2024-08-05
Quarterly 2023-09-30 76098000.0 +20.4% USD 10-Q 2024-11-05
Quarterly 2024-03-31 53174000.0 -30.1% USD 10-Q 2024-05-02
Quarterly 2024-06-30 76799000.0 +44.4% USD 10-Q 2024-08-05
Quarterly 2024-09-30 80507000.0 +4.8% USD 10-Q 2024-11-05
Annual 2019-12-31 183597000.0 USD 10-K 2022-03-01
Annual 2020-12-31 206018000.0 +12.2% USD 10-K 2023-02-28
Annual 2021-12-31 256733000.0 +24.6% USD 10-K 2024-02-27
Annual 2022-12-31 248350000.0 -3.3% USD 10-K 2025-02-27
Annual 2023-12-31 276692000.0 +11.4% USD 10-K 2025-02-27
Annual 2024-12-31 297626000.0 +7.6% USD 10-K 2025-02-27

Net Income

Q: 18 | A: 7

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2020-03-31 -1986000.0 USD 10-Q 2021-05-13
Quarterly 2020-06-30 7252000.0 +465.2% USD 10-Q 2021-08-12
Quarterly 2020-09-30 629000.0 -91.3% USD 10-Q 2021-11-10
Quarterly 2021-03-31 11065000.0 +1659.1% USD 10-Q 2022-05-05
Quarterly 2021-06-30 42615000.0 +285.1% USD 10-Q 2022-08-04
Quarterly 2021-09-30 27444000.0 -35.6% USD 10-Q 2022-11-02
Quarterly 2022-03-31 30641000.0 +11.6% USD 10-Q 2023-05-03
Quarterly 2022-06-30 30418000.0 -0.7% USD 10-Q 2023-08-03
Quarterly 2022-09-30 25090000.0 -17.5% USD 10-Q 2023-11-01
Quarterly 2023-03-31 2842000.0 -88.7% USD 10-Q 2024-05-02
Quarterly 2023-06-30 23513000.0 +727.3% USD 10-Q 2024-08-05
Quarterly 2023-09-30 -13660000.0 -158.1% USD 10-Q 2024-11-05
Quarterly 2024-03-31 6323000.0 +146.3% USD 10-Q 2025-05-01
Quarterly 2024-06-30 8754000.0 +38.4% USD 10-Q 2025-08-08
Quarterly 2024-09-30 16998000.0 +94.2% USD 10-Q 2025-11-04
Quarterly 2025-03-31 -13260000.0 -178.0% USD 10-Q 2025-05-01
Quarterly 2025-06-30 7962000.0 +160.0% USD 10-Q 2025-08-08
Quarterly 2025-09-30 48400000.0 +507.9% USD 10-Q 2025-11-04
Annual 2019-12-31 -20425000.0 USD 10-K 2022-03-01
Annual 2020-12-31 -37491000.0 -83.6% USD 10-K 2023-02-28
Annual 2021-12-31 117121000.0 +412.4% USD 10-K 2024-02-27
Annual 2022-12-31 -233570000.0 -299.4% USD 10-K 2025-02-27
Annual 2023-12-31 51376000.0 +122.0% USD 10-K 2026-02-24
Annual 2024-12-31 44398000.0 -13.6% USD 10-K 2026-02-24
Annual 2025-12-31 77949000.0 +75.6% USD 10-K 2026-02-24

EPS Basic

Q: 18 | A: 7

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2020-03-31 -0.01 USD/shares 10-Q 2021-05-13
Quarterly 2020-06-30 0.03 +400.0% USD/shares 10-Q 2021-08-12
Quarterly 2020-09-30 0.0 -100.0% USD/shares 10-Q 2021-11-10
Quarterly 2021-03-31 0.04 USD/shares 10-Q 2022-05-05
Quarterly 2021-06-30 0.15 +275.0% USD/shares 10-Q 2022-08-04
Quarterly 2021-09-30 0.1 -33.3% USD/shares 10-Q 2022-11-02
Quarterly 2022-03-31 0.11 +10.0% USD/shares 10-Q 2023-05-03
Quarterly 2022-06-30 0.11 +0.0% USD/shares 10-Q 2023-08-03
Quarterly 2022-09-30 0.09 -18.2% USD/shares 10-Q 2023-11-01
Quarterly 2023-03-31 0.01 -88.9% USD/shares 10-Q 2024-05-02
Quarterly 2023-06-30 0.08 +700.0% USD/shares 10-Q 2024-08-05
Quarterly 2023-09-30 -0.05 -162.5% USD/shares 10-Q 2024-11-05
Quarterly 2024-03-31 0.02 +140.0% USD/shares 10-Q 2025-05-01
Quarterly 2024-06-30 0.03 +50.0% USD/shares 10-Q 2025-08-08
Quarterly 2024-09-30 0.06 +100.0% USD/shares 10-Q 2025-11-04
Quarterly 2025-03-31 -0.05 -183.3% USD/shares 10-Q 2025-05-01
Quarterly 2025-06-30 0.03 +160.0% USD/shares 10-Q 2025-08-08
Quarterly 2025-09-30 0.17 +466.7% USD/shares 10-Q 2025-11-04
Annual 2019-12-31 -0.09 USD/shares 10-K 2022-03-01
Annual 2020-12-31 -0.16 -77.8% USD/shares 10-K 2023-02-28
Annual 2021-12-31 0.41 +356.2% USD/shares 10-K 2024-02-27
Annual 2022-12-31 -0.83 -302.4% USD/shares 10-K 2025-02-27
Annual 2023-12-31 0.18 +121.7% USD/shares 10-K 2026-02-24
Annual 2024-12-31 0.16 -11.1% USD/shares 10-K 2026-02-24
Annual 2025-12-31 0.27 +68.8% USD/shares 10-K 2026-02-24

EPS Diluted

Q: 18 | A: 7

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2020-03-31 -0.01 USD/shares 10-Q 2021-05-13
Quarterly 2020-06-30 0.03 +400.0% USD/shares 10-Q 2021-08-12
Quarterly 2020-09-30 0.0 -100.0% USD/shares 10-Q 2021-11-10
Quarterly 2021-03-31 0.04 USD/shares 10-Q 2022-05-05
Quarterly 2021-06-30 0.15 +275.0% USD/shares 10-Q 2022-08-04
Quarterly 2021-09-30 0.1 -33.3% USD/shares 10-Q 2022-11-02
Quarterly 2022-03-31 0.11 +10.0% USD/shares 10-Q 2023-05-03
Quarterly 2022-06-30 0.11 +0.0% USD/shares 10-Q 2023-08-03
Quarterly 2022-09-30 0.09 -18.2% USD/shares 10-Q 2023-11-01
Quarterly 2023-03-31 0.01 -88.9% USD/shares 10-Q 2024-05-02
Quarterly 2023-06-30 0.08 +700.0% USD/shares 10-Q 2024-08-05
Quarterly 2023-09-30 -0.05 -162.5% USD/shares 10-Q 2024-11-05
Quarterly 2024-03-31 0.02 +140.0% USD/shares 10-Q 2025-05-01
Quarterly 2024-06-30 0.03 +50.0% USD/shares 10-Q 2025-08-08
Quarterly 2024-09-30 0.06 +100.0% USD/shares 10-Q 2025-11-04
Quarterly 2025-03-31 -0.05 -183.3% USD/shares 10-Q 2025-05-01
Quarterly 2025-06-30 0.03 +160.0% USD/shares 10-Q 2025-08-08
Quarterly 2025-09-30 0.17 +466.7% USD/shares 10-Q 2025-11-04
Annual 2019-12-31 -0.09 USD/shares 10-K 2022-03-01
Annual 2020-12-31 -0.16 -77.8% USD/shares 10-K 2023-02-28
Annual 2021-12-31 0.41 +356.2% USD/shares 10-K 2024-02-27
Annual 2022-12-31 -0.83 -302.4% USD/shares 10-K 2025-02-27
Annual 2023-12-31 0.18 +121.7% USD/shares 10-K 2026-02-24
Annual 2024-12-31 0.16 -11.1% USD/shares 10-K 2026-02-24
Annual 2025-12-31 0.27 +68.8% USD/shares 10-K 2026-02-24

8-K Material Event Details

69 filings · 147 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

57 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value

All Transactions

Date Insider Title Type Security Shares Price Total Value Post-Tx Shares
2026-03-31 DIMITRIEF ALEXANDER Former SVP, GC and Sec. Other disposed transaction
F
Common Stock, $0.01 par value per share ("Common Stock") 7,941 $14.34 $113,874 312,040
2026-03-06 WARBURG PINCUS & CO. Dir Open-market sell
S
Common Stock, $0.01 par value per share ("Common Stock") 15,000,000 $15.27 $229,050,000 19,102,952
2026-03-02 Petras Michael B. Jr. Chairman & CEO Equity grant / award
A · derivative
Share Appreciation Units 120,124 $0.00 $0 120,124
2026-03-02 Petras Michael B. Jr. Chairman & CEO Exercise / conversion
M · derivative
Share Appreciation Units 89,686 59,790
2026-03-02 Petras Michael B. Jr. Chairman & CEO Equity grant / award
A
Common Stock 240,248 $0.00 $0 692,427
2026-03-02 Petras Michael B. Jr. Chairman & CEO Other disposed transaction
F
Common Stock 79,104 $15.91 $1,258,545 452,179
2026-03-02 Petras Michael B. Jr. Chairman & CEO Other disposed transaction
F
Common Stock 39,552 $15.91 $629,272 531,283
2026-03-02 Petras Michael B. Jr. Chairman & CEO Exercise / conversion
M
Common Stock 89,686 570,835
2026-03-02 Petras Michael B. Jr. Chairman & CEO Other disposed transaction
F
Common Stock 40,302 $15.91 $641,205 481,149
2026-03-02 Petras Michael B. Jr. Chairman & CEO Other disposed transaction
F
Common Stock, $0.01 par value per share ("Common Stock") 31,339 $15.91 $498,603 521,451
2025-12-08 Petras Michael B. Jr. Chairman & CEO Open-market sell
S
Common Stock 39,243 $16.45 $645,547 0
2025-12-08 Petras Michael B. Jr. Chairman & CEO Open-market sell
S
Common Stock 394,861 $16.45 $6,495,463 4,819,393
2025-12-08 Petras Michael B. Jr. Chairman & CEO Open-market sell
S
Common Stock, $0.01 par value per share ("Common Stock") 315,896 $16.45 $5,196,489 552,790
2025-12-03 WARBURG PINCUS & CO. Open-market sell
S
Common Stock, $0.01 par value per share ("Common Stock") 9,720,000 $16.33 $158,727,600 34,102,952
2025-11-10 GTCR INVESTMENT XI LLC Open-market sell
S
Common Stock, $0.01 par value per share ("Common Stock") 12,000,000 $15.65 $187,812,000 29,215,301
2025-09-05 WARBURG PINCUS & CO. Dir Open-market sell
S
Common Stock, $0.01 par value per share ("Common Stock") 12,000,000 $15.11 $181,332,000 61,822,952
2025-08-22 Rutz Michael P President of Sterigenics Open-market sell
S
Common Stock 126,611 $16.38 $2,074,306 450,204
2025-08-05 Lyons Jonathan M. Sr. Vice President, CFO Other disposed transaction
F
Common Stock, $0.01 par value per share ("Common Stock") 11,508 $11.19 $128,775 189,602
2025-05-22 Flynn Karen Equity grant / award
A
Common Stock, $0.01 par value per share ("Common Stock") 19,132 $0.00 $0 39,221
2025-03-03 Petras Michael B. Jr. Chairman & CEO Equity grant / award
A · derivative
Performance Stock Units 149,476 $0.00 $0 149,476
2025-03-03 Petras Michael B. Jr. Chairman & CEO Equity grant / award
A
Common Stock 298,953 $0.00 $0 868,603
2025-03-02 Petras Michael B. Jr. Chairman & CEO Other disposed transaction
F
Common Stock 40,987 $12.47 $511,108 569,650
2025-03-02 Petras Michael B. Jr. Chairman & CEO Other disposed transaction
F
Common Stock 31,872 $12.47 $397,444 610,637
2025-03-02 Petras Michael B. Jr. Chairman & CEO Other disposed transaction
F
Common Stock, $0.01 par value per share ("Common Stock") 27,990 $12.47 $349,035 642,509
2024-11-22 Petras Michael B. Jr. Chairman & CEO Equity grant / award
G
Common Stock, $0.01 par value per share ("Common Stock") 39,243 $0.00 $0 39,243
2024-11-20 Petras Michael B. Jr. Chairman & CEO Other disposed transaction
F
Common Stock, $0.01 par value per share ("Common Stock") 29,250 $13.21 $386,392 670,499
2024-09-10 Petras Michael B. Jr. Chairman & CEO Equity grant / award
G
Common Stock, $0.01 par value per share ("Common Stock") 200,000 $0.00 $0 5,253,580
2024-09-06 WARBURG PINCUS & CO. Dir Open-market sell
S
Common Stock, $0.01 par value per share ("Common Stock") 15,000,000 $15.03 $225,450,000 73,822,952
2024-08-05 Lyons Jonathan M. Sr. Vice President, CFO Other disposed transaction
F
Common Stock, $0.01 par value per share ("Common Stock") 7,659 $14.22 $108,911 110,432
2024-05-24 Flynn Karen Equity grant / award
A
Common Stock, $0.01 par value per share ("Common Stock") 20,089 $0.00 $0 20,089
2024-03-04 WARBURG PINCUS & CO. Dir Open-market sell
S
Common Stock, $0.01 par value per share ("Common Stock") 16,594,363 $14.31 $237,423,849 88,822,952
2024-03-04 Rutz Michael P President of Sterigenics Equity grant / award
A · derivative
Stock Options 68,063 $0.00 $0 68,063
2024-03-04 Rutz Michael P President of Sterigenics Open-market sell
S
Common Stock, $0.01 par value per share ("Common Stock") 83,109 $14.31 $1,189,082 544,409
2024-03-04 Rutz Michael P President of Sterigenics Equity grant / award
A
Common Stock, $0.01 par value per share ("Common Stock") 34,270 $0.00 $0 627,518
2024-03-02 Rutz Michael P President of Sterigenics Other disposed transaction
F
Common Stock, $0.01 par value per share ("Common Stock") 3,063 $14.56 $44,597 593,248
2024-03-02 Rutz Michael P President of Sterigenics Other disposed transaction
F
Common Stock, $0.01 par value per share ("Common Stock") 2,438 $14.56 $35,497 596,311
2023-11-20 Rutz Michael P President of Sterigenics Other disposed transaction
F
Common Stock, $0.01 par value per share ("Common Stock") 1,911 $13.93 $26,620 598,749
2023-08-07 Lyons Jonathan M. Sr. Vice President, CFO Equity grant / award
A · derivative
Stock Options 33,640 $0.00 $0 33,640
2023-08-07 Lyons Jonathan M. Sr. Vice President, CFO Equity grant / award
A
Common Stock, $0.01 par value per share (Common Stock) 76,967 $0.00 $0 76,967
2023-05-26 Wheadon David E. Dir Equity grant / award
A
Common Stock, $0.01 par value per share (Common Stock) 15,712 $0.00 $0 35,691
2023-03-06 Rutz Michael P President of Sterigenics Equity grant / award
A · derivative
Stock Options 53,879 $0.00 $0 53,879
2023-03-06 Rutz Michael P President of Sterigenics Equity grant / award
A
Common Stock, $0.01 par value per share ("Common Stock") 28,425 $0.00 $0 600,660
2023-03-02 Rutz Michael P President of Sterigenics Other disposed transaction
F
Common Stock, $0.01 par value per share ("Common Stock") 2,948 $17.41 $51,325 572,235
2022-11-20 Rutz Michael P President of Sterigenics Other disposed transaction
F
Common Stock, $0.01 par value per share ("Common Stock") 1,911 $6.02 $11,504 575,183
2022-11-07 Petras Michael B. Jr. Chairman & CEO Equity grant / award
A · derivative
Stock Options 2,108,356 $0.00 $0 2,108,356
2022-05-27 Donnini David Dir Equity grant / award
A
Common Stock, $0.01 par value per share ("Common Stock") 10,643 $0.00 $0 25,848
2022-03-02 Hammons Terry SVP, GC and Secretary Equity grant / award
A · derivative
Stock Options 57,471 $0.00 $0 57,471
2022-03-02 Hammons Terry SVP, GC and Secretary Equity grant / award
A
Common Stock, $0.01 par value per share ("Common Stock") 22,466 $0.00 $0 31,257
2021-11-20 Leffler Scott J. CFO and Treasurer Other disposed transaction
F
Common Stock, $0.01 par value per share ("Common Stock") 3,894 $22.54 $87,771 701,206
2021-11-11 Hammons Terry SVP, GC and Secretary Equity grant / award
A · derivative
Stock Options 37,676 $0.00 $0 37,676
2021-11-11 Hammons Terry SVP, GC and Secretary Equity grant / award
A
Common Stock, $0.01 par value per share ("Common Stock") 8,791 $0.00 $0 8,791
2021-08-25 Rutz Michael P President of Sterigenics Open-market sell
S
Common Stock, $0.01 par value per share ("Common Stock") 67,000 $25.03 $1,676,876 554,043
2021-05-28 Wheadon David E. Dir Equity grant / award
A
Common Stock, $0.01 par value per share ("Common Stock") 9,336 $0.00 $0 9,336
2021-03-22 WARBURG PINCUS & CO. Dir Open-market sell
S
Common Stock, $0.01 par value per share ("Common Stock") 13,512,582 $26.12 $352,982,423 105,417,315
2020-11-24 Leffler Scott J. CFO and Treasurer Other disposed transaction
D
Common Stock 115,326 $21.68 $2,500,268 705,100
2020-11-20 Leffler Scott J. CFO and Treasurer Equity grant / award
A · derivative
Stock Options 223,602 $0.00 $0 223,602
2020-11-20 Leffler Scott J. CFO and Treasurer Equity grant / award
A
Common Stock, $0.01 par value per share ("Common Stock") 52,173 $0.00 $0 820,426

Regulatory Activity

Last 12 months to 2025-04-29
Insider Filings (Forms 3/4/5) — 12 months
14
Material Event Filings (8-K) — 12 months
13

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count
For informational purposes only — not guaranteed to be accurate or complete.